Jon Pender is vice president for IP & access, global health, in GlaxoSmithKline’s Government Affairs Department. He is responsible for ensuring that GSK’s approach to sustainably improving access to medicines in the developing world reaches as many people in need as possible, whilst protecting the fundamental business model which underpins the research-based pharmaceutical industry.
Partnerships between the private sector and like-minded organizations are key to securing genuine and lasting change in global development.
read more